OncoSil Medical Ltd News

OncoSil Medical Ltd: OncoSil Signs Distribution Agreements for Nordics and Egypt

Nov 17 16:24 ET

OncoSil Medical Ltd: Investor Webinar

Nov 12 20:58 ET

OncoSil Medical Ltd: First OncoSil Treatment at Instituto Nazionale dei Tumori

Nov 10 16:32 ET

OncoSil Medical Ltd: OncoSil Appoints Rachel Duggan as EMEA Sales Director

Oct 28 18:35 ET

OncoSil Medical Ltd: G-BA Approval received for OncoSil Device

Oct 23 18:56 ET

OncoSil Medical Ltd: Trading Halt

Oct 23 17:42 ET

OncoSil Medical Ltd: OncoSil Medical Limited Receives UKCA Renewal Certificates

Oct 20 17:29 ET

OncoSil Medical Ltd: OncoSil signs distribution agreement with Al Zahrawi Medical

Oct 6 18:50 ET

OncoSil Medical Ltd: Corporate Governance Statement and Appendix 4G

Sep 30 05:05 ET

OncoSil Medical Ltd: Peter Hall elects not to join OncoSil Board

Sep 29 19:19 ET

OncoSil Medical Ltd: 50% Recruitment in TRIPP-FFX and PANCOSIL Clinical Trials

Sep 25 19:05 ET

OncoSil Medical Ltd: Comparative Analysis Indicates Benefits from OncoSil

Sep 17 18:54 ET

OncoSil Medical Ltd: Strong Market Penetration with 30th OncoSil Treatment

Sep 12 19:39 ET

OncoSil Medical Ltd: Significant Growth in Commercial Treatment Sales in Q4 FY24

Aug 14 20:13 ET

OncoSil Medical Ltd: Successful Treatment with OncoSil Device in Turkiye

Aug 14 20:05 ET

OncoSil Medical Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jul 30 20:18 ET

OncoSil Medical Ltd: 5th patient is treated in PANCOSIL trial

Jun 10 18:59 ET

OncoSil Medical Ltd: 200th patient treated with the OncoSil device

Jun 2 18:59 ET

OncoSil Medical Ltd: OncoSil signs distribution agreement for Saudi Arabia

May 22 18:44 ET

OncoSil Medical Ltd: 1st Study in Man Increases Pancreatic Tumor Vascularity

Apr 30 18:28 ET